Pfizer Inc
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer Prevnar Family by Year
Prevnar Family (Prevnar 20 / Apexxnar & Prevnar 13 pneumococcal vaccines) — U.S. revenues ($M) ($M)
Pfizer Prevnar Family: $4,151M in FY2025, down 1.9% from a year earlier.
Where the FY2025 figure comes from
“|| Prevnar family (c) | 6,494 | 6,411 | 1% | 1% | 4,151 | 4,233 | (2%) | 2,342 | 2,178 | 8% | 7%”
Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
Reported in Form 8-K Revenue Tables & Form 10-Q / 10-K Segment Footnotes.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up prevnar Family
Cite this data
StockData. (2026). Pfizer Prevnar Family ($M), annual FY2016–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/prevnar-us
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.